z-logo
open-access-imgOpen Access
Inhibition of Interferon‐γ Signaling byLeishmania donovani
Author(s) -
Mitali Ray,
Albert A. Gam,
Robert A. Boykins,
Richard T. Kenney
Publication year - 2000
Publication title -
the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/315330
Subject(s) - phosphorylation , tyrosine phosphorylation , biology , lipophosphoglycan , signal transduction , leishmania donovani , interferon gamma , microbiology and biotechnology , leishmania , immunology , cytokine , parasite hosting , visceral leishmaniasis , leishmaniasis , world wide web , computer science
Leishmania infection causes marked down-regulation of interferon (IFN)-gamma-induced gene activity in macrophages, but the mechanism of the blockade has not been fully defined. The IFN-gamma signal transduction pathway was analyzed in Leishmania donovani-infected phorbol-differentiated U937 human promonocytic cells. IFN-gamma stimulation induced marked phosphorylation of its own receptor (IFN-gammaR)-alpha chain. Phosphorylation of the receptor subunit was significantly inhibited after 24 h of infection with the parasite, apparently because of decreased amounts of the receptor subunit. Formation of the IFN-gammaR complex, as assessed by tyrosine phosphorylation and association of Jak2, was strongly inhibited in cells infected for 24 h. Inhibition of the IFN-gammaR complex formation correlated with inhibition of STAT1alpha binding to the IFN-gamma response region. Pretreatment with purified parasite lipophosphoglycan before IFN-gamma stimulation had no effect on tyrosine phosphorylation. Thus, inhibition of tyrosine phosphorylation of the IFN-gammaR-alpha chain and subsequent signal transduction are most likely due to the decreased amount of IFN-gammaR-alpha protein after infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here